Product
JR-441
1 clinical trial
1 indication
Indication
MPS III-AClinical trial
Phase I/II Study of Weekly Infusions of JR-441 in Patients With Mucopolysaccharidosis Type IIIAStatus: Recruiting, Estimated PCD: 2029-10-31
1 clinical trial
1 indication